Percutaneous medicine administration kit, medicated, single-use
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
19-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Janssen-Cilag Pty Ltd
Class:
Class IIa
Manufactured by:
Cilag AG Hochstrasse 201, SCHAFFHAUSEN, CH8200 Switzerland
Therapeutic area:
45156 - Medicine administration kit, percutaneous, medicated, single-use
Therapeutic indications:
A kit for the intramuscular administration of the medicine Risperdal Consta. Kit includes the medicine Risperdal Consta; a prefilled syringe containing a dilutent; one needle-free vial access device; two needles with needle protection devices (21g for deltoid administration and a 20g for gluteal administration).
Authorization status:
A
Authorization date:
2006-04-07
